Cencora, Inc. (COR) stock price, quote and key numbers

Updated 28 September 2026, 09:52 ET

Cencora, Inc. (COR) closed at $306.92 on 25 September 2026, down 1.0%. That leaves it down 0.6% over a week, down 6.4% over a month and down 0.5% over a year. That is 47% of the way up its 52 week range of $244.82 to $377.54. The median analyst price target of $350 sits 14.0% above the close.

The price

Last close$306.92
Day-0.95%
1 week-0.60%
1 month-6.37%
3 months+7.27%
6 months-3.49%
Year to date-9.13%
1 year-0.47%
52 week high$377.54
52 week low$244.82
Volume1,084,057
Average volume, 3 months1,372,631
Market cap$59.1B

Changes compare dividend and split adjusted closes over trading sessions, so the one year figure is the last close against the close 252 sessions earlier. The 52 week range uses the daily highs and lows of the same window. Read the guide: How to read a stock quote.

The live price, the day's chart and the pre market and after hours prints are in the app: open COR in Just Stock Quotes.

Trend and range

COR trades below both its 50 day average of $317.50 and its 200 day average of $319.13, the shape of a downtrend. The 50 day average sits below the 200 day average. Its beta against the S&P 500 over the last year is -0.14, a stock that barely follows the market. It is 18.7% below its 52 week high and 25.4% above its 52 week low.

50 day average$317.50
200 day average$319.13
Above 50 dayNo
Above 200 dayNo
Beta, 1 year-0.14
Range position47%

Moving averages smooth the closes of the last 50 and 200 sessions; being above or below them describes the trend, it does not predict it. Beta is how much the stock moved for each move in the S&P 500 over the year. Read the guide: Moving averages, the 52 week range and beta.

What analysts say

In the last 90 days 6 firms recorded 7 actions on COR: 6 kept a view and 1 new initiation. Price targets: 5 raised. The most recent targets from 10 firms run from $285 to $430, with a median of $350, 14.0% above the last close.

Actions, 90 days7
Firms6
Median target$350
Median vs close+14.04%
DateFirmActionPrice target
8 Sep 2026RBC CapitalReiterates Sector Perform$330.00
19 Aug 2026RBC CapitalInitiates Coverage On Sector Perform$330.00
11 Aug 2026Wells FargoMaintains Overweight$331.00 to $395.00
7 Aug 2026Morgan StanleyMaintains Overweight$342.00 to $346.00
7 Aug 2026JP MorganMaintains Overweight$382.00 to $390.00
6 Aug 2026UBSMaintains Buy$412.00 to $430.00

A target is one firm's guess at the price a year out, and the average runs optimistic. The useful reading is the mood: high targets and a wall of buys mean high expectations. Read the guide: What analyst ratings and price targets tell you.

Earnings

The next report is on the calendar for 4 November 2026 for Q4 2026, with earnings per share expected at $4.55. The last report, on 5 August 2026 for Q3 2026, showed EPS of $4.48 against $4.36 expected, a beat of 2.8%, on revenue of $84.8 billion. Cencora, Inc. beat the EPS estimate in 8 of its last 8 reported quarters.

Set a percent move alert before the report and the app pings you when the stock reacts, even after hours: open COR in Just Stock Quotes.

The numbers

Over the trailing twelve months Cencora, Inc. shows revenue growth of N.A., a gross margin of N.A., an operating margin of N.A. and a return on equity of N.A..

Margins say how much of each dollar of sales becomes profit, returns say how hard the balance sheet works, and debt to equity says how much of it is borrowed. The valuation ratios, price to earnings and the rest, are in the app on the stock page. Read the guide: The valuation ratios on a stock page.

About Cencora, Inc.

Exchange
NYSE
Sector
Health Care
Industry
Wholesale
Headquarters
Chesterbrook, Pennsylvania
Chief executive
Steven H. Collis
Employees
42,000
Website
www.cencora.com

Cencora, Inc. sources and distributes pharmaceutical products. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

In the same sector

Other Health Care names in the S&P 500, by market cap:

LLY Eli Lilly & Co.JNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co. Inc.UNH UnitedHealth Group Inc.TMO Thermo Fisher Scientific Inc.AMGN Amgen Inc.GILD Gilead Sciences, Inc.

Learn

Add COR to your watchlist, set a price alert, watch the live chart and ask FundSpec AI about it. No account, no subscription. The same screen is in the iPhone, iPad and Android apps.

Open COR in Just Stock Quotes